Roger Perlmutter, Merck R&D chief (Institute for Systems Biology via YouTube)
October 2, 2020 08:46 AM EDTUpdated 11:14 AM
People
R&D

Mer­ck R&D chief Roger Perl­mut­ter is hand­ing off the big job to the ex­ec in charge of dis­cov­ery

John Carroll

Editor & Founder

Af­ter a 7-year run as one of the most suc­cess­ful R&D chiefs in Big Phar­ma, Roger Perl­mut­ter is step­ping away from his post at Mer­ck …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

TRENDING NOW

New fund will pres­sure flail­ing biotechs, as in­vestor frus­tra­tion boils over

Ake­so shares new da­ta sug­gest­ing it can beat Keytru­da on sur­vival, wins Chi­na ap­proval

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

Ab­b­Vie com­mits $10B to ex­pand US foot­print with the threat of tar­iffs ahead

J&J re­ports dura­bil­i­ty da­ta for blad­der can­cer 'pret­zel' drug af­ter FDA fil­ing

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times